Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
(Reuters) – Merck on Wednesday agreed to acquire privately held biotech EyeBio for as much as $3 billion, the latest…
(Reuters) – Merck on Wednesday agreed to acquire privately held biotech EyeBio for as much as $3 billion, the latest…
(Reuters) – BlackRock’s iShares Bitcoin Trust has become the world’s largest fund for the original cryptocurrency, racking up nearly $20…
WASHINGTON (Reuters) – The National Highway Traffic Safety Administration on Wednesday said it is seeking records from Tesla in its…
(Reuters) -Sam Altman-led OpenAI said on Wednesday it has signed content and product partnerships with The Atlantic and Vox Media,…